REGENERON PHARMACEUTICALS, INC. (REGN)

REGENERON PHARMACEUTICALS, INC. (REGN) public financial performance, SEC filing summary, and valuation metrics.

Financial highlights

Contract Revenue: 1899700000 usd (2026-03-31)
Operating Income: 642900000 usd (2026-03-31)
Net Income: 727200000 usd (2026-03-31)
Operating Income: 3577900000 usd (2025-12-31)
Net Income: 4504900000 usd (2025-12-31)
Contract Revenue: 7331200000 usd (2025-12-31)
Net Income: 1460000000 usd (2025-09-30)
Contract Revenue: 1968400000 usd (2025-09-30)
Operating Income: 1026800000 usd (2025-09-30)
Net Income: 1391600000 usd (2025-06-30)
Operating Income: 1079500000 usd (2025-06-30)
Contract Revenue: 1860700000 usd (2025-06-30)
Operating Income: 591700000 usd (2025-03-31)
Contract Revenue: 1531200000 usd (2025-03-31)
Net Income: 808700000 usd (2025-03-31)
Operating Income: 3990700000 usd (2024-12-31)
Contract Revenue: 6057800000 usd (2024-12-31)
Net Income: 4412600000 usd (2024-12-31)
Operating Income: 1179500000 usd (2024-09-30)
Contract Revenue: 1660100000 usd (2024-09-30)